TMCI: treace.com Growth-Adjusted Market Cap to Net Income
The P/E ratio relative to medium-term growth underscores the reliability of Treace Medical Concepts (TMCI) orthopedic tool logistics, where resource diversification ensures supply stability. The integration of the Lapiplasty 3D system into physician training solidifies the brand's technological dominance in foot surgery. Steady demand for consumables ensures a predictable capital inflow. The value of 0.00 shows the current level of this parameter.
Treace Medical Concepts (TMCI) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio Treace Medical Concepts|TMCI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital treace.com|TMCI - Company Debts|Debt to Book Value Treace Medical|TMCI - Company Long-Term Debts|Short-Term Debt Treace Medical Concepts|Immediate Liquidity Ratio treace.com
- earnings and valuation multiples indicators:
TMCI - Net Profit|Company Profit Forecast Treace Medical Concepts|TMCI - P/E Multiple|Projected Price to Earnings Treace Corp|TMCI - PEG Multiple|EV/EBITDA Multiple Treace Medical|TMCI - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Treace Medical Concepts|TMCI - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months treace.com|TMCI - Earnings growth in current year|Expected net earnings per share growth next year Treace Medical Concepts
Fundamental company analysis:TMCI (Treace Medical Concepts Inc)
Investors use this ratio to identify undervalued assets by comparing the current P/E multiple with earnings growth rates. Tracking the PEG ratio allows for the mathematical confirmation of Treace Medical Concepts (TMCI) growth potential, given the company's expansion into the 3D foot correction segment and the significant volume of the untapped specialized orthopedic surgery market.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight Corp) - Price/Earnings to Growth Multiple|ClearPoint Neuro - Growth-Adjusted Payback Ratio|STXS (Stereotaxis, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate neurostar.com STIM|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|AMIX (autonomix.com) - Price/Earnings to Growth Multiple|IVF: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Bone Biologics Corp|AXNX: Growth-Adjusted Payback Ratio|PEG Multiple BIOL|DYNT - Price to Earnings Adjusted for Growth Rate|PEG Multiple FNA (Paragon 28)|PEG Multiple INVO Bioscience Inc. INVO
